임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

35건 표시

1상상태 미확인· Erosive Gastroesophageal Reflux Disease
to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
리드: 대웅제약
상세 →NCT06437951
1상상태 미확인· Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT06119945
1상상태 미확인· Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT06109259
1상상태 미확인· Drug Drug Interaction
Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
리드: 대웅제약
상세 →NCT06119958
1상상태 미확인· Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT06010589
1상상태 미확인· Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT05954247
1상상태 미확인· Healthy Volunteers
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT05954338
1상상태 미확인· Diabetes Mellitus, Type 2
To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
리드: 대웅제약
상세 →NCT05747664
1상상태 미확인· Healthy
To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT05797922
1상상태 미확인· Phase 1 Study, Healthy Volunteers
A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects
리드: 대웅제약
상세 →NCT05868967
1상상태 미확인· Drug-drug Interaction
Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects
리드: 대웅제약
상세 →NCT05699070
1상상태 미확인· FDC
To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
리드: 대웅제약
상세 →NCT05737771
1상상태 미확인· Drug Drug Interaction
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
리드: 대웅제약
상세 →NCT05812404
1상상태 미확인· Healthy
Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults
리드: 대웅제약
상세 →NCT05500898
1상상태 미확인· Healthy
Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities
리드: 대웅제약
상세 →NCT05207176
1상상태 미확인· Healthy Volunteers
The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults
리드: 대웅제약
상세 →NCT05321732
1상상태 미확인· Healthy
Pharmacokinetics and Safety of DWJ1451 in Healthy Adults
리드: 대웅제약
상세 →NCT04819932
1상상태 미확인· Healthy
Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT04827472
1상상태 미확인· COVID-19 Patients
To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
리드: 대웅제약
상세 →NCT04592835
1상상태 미확인· Healthy
Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers
리드: 대웅제약
상세 →NCT04477369
1상상태 미확인· Healthy
To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19
리드: 대웅제약
상세 →NCT04524052
1상상태 미확인· Healthy Male Volunteers
Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
리드: 대웅제약
상세 →NCT04490434
1상상태 미확인· Healthy
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults
리드: 대웅제약
상세 →NCT04343547
1상상태 미확인· Type2 Diabetes
Type 2 Diabetes Patients With Renal Impairment
리드: 대웅제약
상세 →NCT04221399
1상상태 미확인· Healthy
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)
리드: 대웅제약
상세 →NCT04185805
1상상태 미확인· Healthy
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)
리드: 대웅제약
상세 →NCT04167267
1상상태 미확인· Healthy
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers
리드: 대웅제약
상세 →NCT04003441
1상상태 미확인· Healthy
Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
리드: 대웅제약
상세 →NCT03947528
1상상태 미확인· Prostate Cancer
Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer
리드: 대웅제약
상세 →NCT03029533
1상상태 미확인· Healthy
Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers
리드: 대웅제약
상세 →NCT03016520
1상상태 미확인· Healthy
Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers
리드: 대웅제약
상세 →NCT03005223
1상상태 미확인· Healthy
Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects
리드: 대웅제약
상세 →NCT03016494
1상상태 미확인· Healthy
Study of DWJ1351 in Healthy Male Volunteers
리드: 대웅제약
상세 →NCT02665832
1상상태 미확인· Healthy
A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers
리드: 대웅제약
상세 →NCT02561884
1상상태 미확인· Rheumatoid Arthritis
Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers
리드: 대웅제약
상세 →NCT01635686

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.